Table 2.

Characteristics of patients who underwent surgical treatment of post-transplant bronchial stenoses

	Sex/age	Disease requiring BLTX	Time between BLTX and stenosis detection (months)	Airway stenosis	Site of bronchial stenosis required management	Endoscopic strategies	Time between stenosis detection and surgical management (months)
Pt 1	M/49 years	Alpha-1 AT deficiency	3	Bilateral	Bronchus intermedius	Endoscopic dilatation, laser ablation, self-expandable stent	1
Pt 2	F/47 years	Bronchiectasis	27	Right–sided	Bronchus intermedius	Endoscopic dilatation, laser ablation	16
Pt 3	M/36 years	CF	3	Right–sided	Bronchus intermedius until the origin of middle and lower right lobar bronchi	Endoscopic dilatation, laser ablation, self-expandable stent	8
Pt 4	M/61 years	COPD	3	Right–sided	Right main bronchus, up to the tracheobronchial angle, bronchus intermedius until the origin of middle and lower right lobar bronchi	Endoscopic dilatation, laser ablation, self-expandable stent	19
Pt 5	F/26 years	CF	11	Right–sided	Bronchus intermedius until the emergence of middle and lower right lobar bronchi	Endoscopic dilatation, laser ablation, brachytherapy	88
Pt 6	M/53 years	Pulmonary fibrosis and Pc-PH secondary to Systemic Scleroderma	2	Right–sided	Bronchus intermedius	Endoscopic dilatation, laser ablation	5

AT antitrypsin, BLTX bilateral lung transplantation, CF cystic fibrosis, COPD chronic obstructive pulmonary disease, F female, M male, pc-PH precapillary pulmonary hypertension, Pt patient